Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. AWK
10. ACN

Go back to Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update

Corcept Therapeutics (CORT) Tops Q4 EPS by 3c

February 25, 2019 4:18 PM EST

Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $66.8 million versus the consensus estimate of $69.61 million.

GUIDANCE:

Corcept Therapeutics sees FY2019 revenue of $285-315 million, versus the consensus of... More